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The present study was carried out to understand the adaptive strategies developed by
Stenotrophomonas maltophilia for chronic colonization of the cystic fibrosis (CF) lung.
For this purpose, 13 temporally isolated strains from a single CF patient chronically
infected over a 10-year period were systematically characterized for growth rate,
biofilm formation, motility, mutation frequencies, antibiotic resistance, and pathogenicity.
Pulsed-field gel electrophoresis (PFGE) showed over time the presence of two distinct
groups, each consisting of two different pulsotypes. The pattern of evolution followed
by S. maltophilia was dependent on pulsotype considered, with strains belonging to
pulsotype 1.1 resulting to be the most adapted, being significantly changed in all traits
considered. Generally, S. maltophilia adaptation to CF lung leads to increased growth
rate and antibiotic resistance, whereas both in vivo and in vitro pathogenicity as well
as biofilm formation were decreased. Overall, our results show for the first time that
S. maltophilia can successfully adapt to a highly stressful environment such as CF
lung by paying a “biological cost,” as suggested by the presence of relevant genotypic
and phenotypic heterogeneity within bacterial population. S. maltophilia populations
are, therefore, significantly complex and dynamic being able to fluctuate rapidly under
changing selective pressures.
Keywords: cystic fibrosis, lung infections, Stenotrophomonas maltophilia, chronic infection, biofilm, virulence,
antibiotic-resistance
INTRODUCTION
Stenotrophomonas maltophilia is one of the most common emerging multi-drug resistant
pathogens found in the lungs of people with cystic fibrosis (CF) where its prevalence is increasing
(Amin and Waters, 2014; Green and Jones, 2015; Salsgiver et al., 2016). Nevertheless, it is unclear
whether S. maltophilia simply colonizes the lungs of people with CF without adverse effect or
Abbreviations: CF, cystic fibrosis; TSB, Trypticase soy broth; MHA, Mueller-Hinton agar; PFGE, pulsed-field gel
electrophoresis; MGT, mean generation time; SBF, specific biofilm formation index; MOI, multiplicity of infection.
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causes true infection leading to pulmonary inflammation and
clinical deterioration. Clinical studies reported conflicting results
on the correlation between the presence of this microorganism
and lung damage (Karpati et al., 1994; Goss et al., 2002). It has
recently been shown that chronic infection with S. maltophilia
in people with CF is an independent risk factor for pulmonary
exacerbation requiring hospitalization and antibiotics and was
associated with a systemic immune response to S. maltophilia
(Waters et al., 2011).
In a series of studies, we found evidence highly suggestive
of the pathogenic role of S. maltophilia in CF patients. This
microorganism can grow as biofilm not only on abiotic surfaces
(Di Bonaventura et al., 2004, 2007a,b; Pompilio et al., 2008)
but also on CF-derived epithelial monolayer (Pompilio et al.,
2010), probably because of a selective adaptation to CF airways
(Pompilio et al., 2011). Furthermore, in a murine model of
acute respiratory infection we observed that S. maltophilia
significantly contributes to the inflammatory process resulting
in compromised respiratory function and death (Di Bonaventura
et al., 2010).
In the diseased CF lung, pathogens are exposed to a complex
range of selection pressures including host physiological factors,
oxygen tension, immune responses, therapeutic antimicrobials,
and competing microorganisms. Together, these are thought to
drive genetic and phenotypic diversity in the pathogen over time.
Consequently, various airway-specific adaptations are postulated
to favor persistence and lead to host-tolerant clonal lineages
that are less cytotoxic, better at evading the immune system,
more resistant to antimicrobials and less metabolically active
than their ancestral strains (Hill et al., 2005; Bragonzi et al.,
2009; Behrends et al., 2013). These studies have been largely
focused on Pseudomonas aeruginosa (Hogardt and Heesemann,
2010; Hauser et al., 2011). In comparison, the adaptation of
S. maltophilia in the CF lung has been investigated rarely (Vidigal
et al., 2014), and is largely unknown.
In order to understand the adaptive strategies developed
by S. maltophilia for chronic colonization of the CF lung, we
systematically characterized 12 temporally isolated strains from a
single CF patient over a 10-year period. We studied their relative
growth rate, biofilm formation, motility, mutation frequencies,
antibiotic resistance spectrum, virulence, and pathogenicity. We
report for the first time that chronic S. maltophilia displays
unusual adaptive plasticity by modulating its virulence and
pathogenicity, yet exacerbating antibiotic resistance and other
factors that augment its fitness in the CF lungs.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Thirteen S. maltophilia isolates, collected during 11 year-period
(2004–2014) from sputum of a CF patient (ethically coded “ZC”)
at the CF Unit of “Bambino Gesù” Children’s Hospital and
Research Institute of Rome, were investigated in this study. One
strain per year was considered, except than for 2012 and 2013
when two strains were obtained during the same year. The patient
was selected owning to clinically defined chronic infection with
S. maltophilia, which mandates at least 50% of samples must
be positive in the preceding 12 months (Pressler et al., 2011).
S. maltophilia was co-cultured with P. aeruginosa in 2010, 2011,
and 2014 only. Each strain was identified by the Vitek automated
system (bioMérieux Italia SpA; Florence, Italy), then stored at
−80◦C until use, when it was grown at 37◦C in Trypticase
Soy broth (TSB; Oxoid SpA; Garbagnate M.se, Milan, Italy)
or Mueller-Hinton agar (MHA; Oxoid) plates. S. maltophilia
ATCC13637 reference strain, and S. maltophilia Sm111, knock-
out for fliI-gene (Pompilio et al., 2010), were used as controls in
mutation frequency and motility assays, respectively.
Bacterial Genotyping
The epidemiological relatedness of the strains was studied by
pulsed-field gel electrophoresis (PFGE), as previously described
(Pompilio et al., 2011). Agarose-embedded DNA was digested
with the restriction enzyme XbaI, and then separated with
6V/cm for 20 h at 12◦C, with pulse times 5–35 s and an included
angle of 120◦. PFGE profiles were analyzed by visual inspection
and isolates were considered as belonging to the same PFGE
cluster if they differed by ≤3 bands (Gherardi et al., 2015).
Isolates with indistinguishable PFGE profiles belonged to the
same pulsotype.
Growth Rate
Overnight cultures in TSB were corrected with fresh TSB to an
OD550 of 1.00, corresponding to about 1–5 × 109 CFU/ml. This
suspension was diluted 1:100 in fresh TSB, then 200µl were
dispensed in eachwell of amicrotiter plate (Kartell SpA; Noviglio,
Milan, Italy), and incubated at 37◦C, under static conditions,
in a microplate reader (Sinergy H1 Multi-Mode Reader; BioTek
Instruments, Inc., Winooski, VT, USA). OD550 readings were
taken every 30min for 24 h. Considering the exponential growth
phase selected on a graph of ln OD550 vs. time (t), mean
generation time (MGT) was calculated as follows: MGT= ln2/µ,
where µ (growth rate)= (lnODt − lnODt0)/t.
Biofilm Formation
Biofilm formation was assayed as described by Pompilio et al.
(2008). Two-hundred microliters of the 1:100 diluted inoculum
(prepared as described in “Growth Rate”) were dispensed to each
well of a flat bottom 96-well polystyrene tissue culture-treated
plate (Falcon BD; Milan, Italy), and incubated in static culture
at 37◦C for 24 h. Samples were washed twice with PBS (pH
7.3; Sigma-Aldrich Co., Milan, Italy), then crystal violet-stained
biomass was quantified by measuring the optical density at 492
nm (OD492). Biofilm biomass was normalized on the growth rate
by calculating the “Specific Biofilm Formation” (SBF) index as
follows: SBF= biofilm biomass (OD492)/growth rate (µ).
Motility
Swimming, swarming, and subsurface twitching assays were
performed as described by Rashid and Kornberg (2000), with
modification. Swimming and swarming were assessed by surface
inoculating a single colony onto swimming agar (10 g/l tryptone,
5 g/l NaCl, 3 g/l agar) or into swarming (8 g/l nutrient broth, 5 g/l
dextrose, and 5 g/l agar) agar. After incubation at 37◦C for 24 h,
the growth zone was measured in millimeters. Twitching was
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measured by inoculating a single colony to the bottom of Petri
dish containing 1% TSB solidified with 1% agar. Twitch zones
were stained with crystal violet after 72 h of incubation at 37◦C,
and measured in millimeters.
Mutation Frequencies
Mutation frequency of each strain was assessed according
to Oliver et al. (2000), with modification. For each sample,
three tubes containing 20ml of Mueller-Hinton broth (Oxoid)
were inoculated with one independent colony, obtained from
overnight-growth on MHA plate, and incubated overnight
with agitation (130 rpm). Samples were centrifuged (4500 rpm,
10min, 4◦C) and pellets resuspended in 1ml of Mueller-Hinton
broth. Ten-fold dilution of each sample was seeded onto MHA
plates (controls) and onto MHA added with rifampin (Sigma-
Aldrich) 250µg/ml. Colony counts were performed after 24 h of
incubation of the MHA plates and after 48 h of incubation of the
MHA-rifampin plates. Mutation frequency was calculated as the
number of rifampin-resistant colonies in proportion to the total
viable count. Strains were classified into four categories based on
mutation frequency (f ) (Turrientes et al., 2010): hypo-mutators
(f ≤ 8 × 10−9), normo-mutators (8 × 10−9 < f < 4 × 10−8),
weak-mutators (4× 10−8 ≤ f < 4× 10−7), and strong-mutators
(f ≥ 4× 10−7).
Virulence Assays
The virulence potential of S. maltophilia strains was evaluated
both in vivo in Galleria mellonella larvae, and in vitro
on human A549 alveolar basal epithelial cells. (i) Galleria
mellonella infection assays were performed as described by Betts
et al. (2014), with minor modifications. Overnight cultures of
S. maltophilia grown in TSB were washed and resuspended in
PBS. Twenty larvae were inoculated with each S. maltophilia
strain at doses of 103, 104, 105, and 106 CFU/larva, or PBS only
(controls). Ten microliters of the bacterial suspension or PBS
were injected directly into the hemocoel of the wax moth via
the right proleg using 10-µL Hamilton syringe (Hamilton Co.,
Nevada, USA). Larvae were incubated in the dark at 37◦C and
checked daily for survival until 96 h. Larvae were considered dead
if they failed to respond to touch. A “pathogenicity score” was
assigned to each strain, considering both time and dose needed
to achieve LD50. The higher the score, the higher the virulence.
(ii) S. maltophilia co-culture infection assays on human
respiratory epithelial cells were performed according to Karaba
et al. (2013), with minor modifications. Human A549 alveolar
basal epithelial cells (ATCC CCL-185) were seeded at 105
cells/ml in 24-mm diameter cell culture polyester inserts in
6-well TranswellTM plates (Corning; USA). Monolayers were
grown overnight (37◦C, 5% CO2) in DMEM (high glucose)
with 1% penicillin, streptomycin, amphotericin (HiMedia;
Mumbai, India), and supplemented with 10% fetal bovine serum
(Invitrogen, USA). Each S. maltophilia strain, grown in TSB
medium, was added to each well at Multiplicity-Of-Infection
(MOI) of 500 on the apical surface of the monolayer insert.
The co-culture sets were incubated for 24 h at 37◦C in 5% CO2,
gently washed to remove suspended bacteria and dead epithelial
cells, and then subjected to Live/DeadTM assay (ThermoFisher
Scientific; Rodano, Milan, Italy). Cell death, cell rounding,
and loss of adherence were studied. Images were acquired
on Olympus FLUOVIEW FV1000 confocal laser scanning
microscope (excitation: 488 and 543 nm; emission: 505–526
and 612–644 nm, respectively). Quantitative image analysis was
performed using FV1000 Viewer-1.7 for fluorescence intensity,
and the percent cell death was calculated against total cell
population in the respective set.
MIC Determination
The in vitro susceptibility of S. maltophilia strains to
trimethoprim-sulfamethoxazole, minocycline, ciprofloxacin,
levofloxacin, ticarcillin-clavulanate, ceftazidime, piperacillin-
tazobactam, amikacin, and chloramphenicol was assessed
by MIC-Test Strip (Liofilchem; Roseto degli Abruzzi, Italy),
according to CLSI guidelines [Clinical Laboratory Standards
Institute (CLSI), 2016]. In the case of piperacillin-tazobactam,
amikacin, and ciprofloxacin, because no breakpoints are
available for S. maltophilia, we used those established for P.
aeruginosa [Clinical Laboratory Standards Institute (CLSI),
2016]. Escherichia coli ATCC 25922 and P. aeruginosa ATCC
27853 were chosen as quality control strains in each batch of
tests.
Statistical Analysis
Each test was performed in triplicate and repeated on two
different occasions. Statistical analysis was performed using
Prism 6 for Windows software (version 6.01; GraphPad Software
Inc., La Jolla, USA). Gaussian distribution was evaluated by
Kolmogorov–Smirnov-test with Dallal-Wilkinson-Lille for p-
value. Differences were measured using both parametric (one-
way ANOVA-test followed by Tukey’s multiple comparison post-
test), and non-parametric (Mann–Whitney-test; Kruskal–Wallis
ANOVA-test followed by Dunn’s multiple comparison post-
test) tests. Linear regression analysis was used to assess the
significance of a trend. Spearman correlation coefficient was
calculated for correlation analysis. MIC-values were considered
as discordant for discrepancies ≥ 2 log2 concentration steps.
Statistical significance was set at 0.05.
RESULTS
Bacterial Genotyping
We first assessed the clonality of strains isolated from patient ZC
at different time points during the course of chronic infection
over 11 years. Based on PFGE patterns, two distinct PFGE
groups, with four different pulsotypes, were identified among
S. maltophilia isolates according to the previously described
interpretative criteria (Figure 1). PFGE group 1 encompassed
two related PFGE subtypes, namely pulsotype 1.1, consisting of
two strains (ZC2005 and ZC2011), and pulsotype 1.2, consisting
of three strains (ZC2010, ZC2012-STM1, and ZC2013-STM1);
PFGE group 2 comprised two related PFGE subtypes, pulsotype
2.1, consisting of six strains (ZC2006, ZC2008, ZC2009,
ZC2012-STM2, ZC2013-STM2, and ZC2014); and pulsotype 2.2,
consisting of ZC2007 strain only. Strains isolated both in 2012
(ZC2012-STM1 and ZC2012-STM2) and 2013 (ZC2013-STM1
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FIGURE 1 | Clonal relatedness of S. maltophilia strains, as assessed by PFGE analysis. The similarity of PFGE profiles was visually assessed, and considered
as follows: (i) isolates with identical PFGE patterns were assigned to the same PFGE type and subtype; (ii) isolates differing by one to three bands were assigned to the
same PFGE type and were considered genetically related; while (iii) isolates with PFGE patterns differing by more than four bands were considered genetically
unrelated and were assigned to different PFGE types. Four pulsotypes were observed: 1.1 (yellow), 1.2 (green), 2.1 (blue), and 2.2 (purple). STD, molecular weight
standard. The profile exhibited by ZC2004 strain could not be interpreted because of poor resolution and, consequently, was not assigned to a pulsotype and not
enrolled in the study.
and ZC2013-STM2) belonged to different pulsotypes of unrelated
PFGE types. The profile exhibited by ZC2004 strain could not be
interpreted because of lack of resolution in the high molecular
weight zone of the gel and, therefore, was not further studied.
Growth Rate
Growth rate values exhibited by each S. maltophilia strain were
spectrophotometrically assessed, and results are summarized in
Figures 2A, 3A.
S. maltophilia strains isolated over time significantly differed
for growth rate (p < 0.0001, Kruskal–Wallis-test), showing a
significant upward trend (p < 0.01; Table 1).
Significant differences were observed within each pulsotype
(Figure 2A). With regard to strains belonging to pulsotype 1.1,
ZC2011 showed a growth rate higher compared to ZC2005
(median: 0.402 vs. 0.217, respectively; p < 0.01). With regard
to pulsotype 1.2, ZC2010 strain showed a median growth rate
significantly higher than ZC2012-STM1 (median: 0.429 vs. 0.316,
respectively; p < 0.05). Among pulsotype 2.1 strains, ZC2013-
STM2 grew significantly faster than ZC2006 and ZC2009 strains
(median: 0.465 vs. 0.292 and 0.279, respectively; p < 0.01).
Considering each pulsotype as a whole, no statistically
significant differences were observed (Figure 3A). The kinetics
of changes in growth rate showed that both pulsotypes 1.1 and
2.1 significantly increased over the study-period (p < 0.0001
and 0.05, respectively), while pulsotype 1.2 remained generally
unchanged (Table 1).
Biofilm Formation
The results concerning biofilm biomass formed by each strains
tested were normalized on growth rate and expressed as SBF,
as shown in Figures 2B, 3B. SBF-values were statistically related
to non-normalized biofilm OD492-values (data not shown;
Spearman r: 0.986; p < 0.0001).
S. maltophilia strains significantly differed for efficacy in
forming biofilm (p < 0.0001, Kruskal–Wallis + Dunn post-
test). Significant differences were found among strains belong
to each pulsotype (Figure 2B). With regard to pulsotype 1.1
strains, ZC2005 produced significantlymore biofilm compared to
ZC2011 (median: 16.19 vs. 0.34, respectively; p< 0.0001). Among
strains belonging to pulsotype 1.2, ZC2010 formed significantly
more biofilm biomass than other strains (median: 2.23 vs. 1.02,
and 1.06, respectively, for ZC2010, ZC2012-STM1, and ZC2013-
STM1 strains; p< 0.0001).With regard to pulsotype 2.1, ZC2012-
STM2 produced higher biofilm biomass compared to most of
other strains (median: 1.79 vs. 0.76, 1.06, and 0.19; respectively,
for ZC2012-STM2, ZC2008, ZC2013-STM2, and ZC2014 strains;
p < 0.0001).
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FIGURE 2 | Phenotypic traits exhibited by S. maltophilia strains. Colors indicate the pulsotypes: 1.1 (yellow, n = 2 strains), 1.2 (green, n = 3 strains), 2.1 (blue,
n = 6 strains), and 2.2 (purple, n = 1 strain). (A) Growth rate, expressed as generation time (U/h). (B) Biofilm biomass formation, normalized on growth rate and
expressed as specific biofilm formation (SBF) index. (C) Mutation frequency; strains were classified into four categories based on mutation frequency (f ):
hypo-mutators (f ≤ 8 × 10−9), normo-mutators (8 × 10−9 < f < 4 × 10−8), weak-mutators (4 × 10−8 ≤ f < 4 × 10−7), and strong-mutators (f ≥ 4 × 10−7). (D)
Swimming motility, expressed as diameter of growth zone (mm). (E) Twitching motility, expressed as diameter of twitch zone (mm). Results are shown as box and
whiskers (n = 6, for each strain): the box always extends from the 25th to 75th percentiles, while the line in the middle of the box is plotted at the median. Statistical
analysis: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, Mann–Whitney-test (pulsotype 1.1) or Kruskal–Wallis followed by Dunn’s multiple comparison post-test
(pulsotypes 1.2 and 2.1).
Pulsotypes significantly differed for biofilm formation (p <
0.0001, Kruskal–Wallis-test; Figure 3B). In particular, pulsotype
1.1 produced significantly more biofilm than 2.1 and 2.2
(median: 6.99 vs. 0.93 and 2.63, respectively; p < 0.01 and
0.05, respectively), pulsotype 2.2 formed a biofilm biomass
significantly higher than 1.2 (median: 1.2; p < 0.01) and 2.1 (p
< 0.001), while pulsotype 1.2 produced higher biofilm amount
than 2.1 (p < 0.01; Figure 3B).
The kinetics of biofilm biomass formed during the study-
period showed a significant downward trend for pulsotypes 1.1
and 2.1 (p < 0.0001; Table 1).
Mutation Frequency
Variations in the frequency of mutation exhibited by
S. maltophilia strains isolated over 10 years are summarized
in Figures 2C, 3C.
Mutation frequency significantly differed among
S. maltophilia strains (p < 0.0001, Kruskal–Wallis-test),
while no significant trend was observed (Table 1). Significant
differences were found among strains belong to each pulsotype
(Figure 2C). Among pulsotype 1.1 strains, ZC2005 showed a
mutation frequency significantly lower than ZC2011 (median:
9.9 × 10−8 vs. 1.0 × 10−6, respectively; p < 0.05). With regard
to pulsotype 2.1, strains ZC2008 and ZC2009 exhibited higher
mutation frequency (median: 7.9 × 10−8 and 6.2 × 10−8,
respectively) compared to ZC2006 and ZC2012-STM2 (median:
1.8 × 10−8 and 1.2 × 10−8, respectively; p < 0.05 and 0.01,
respectively). Strains belonging to pulsotype 1.2 did not change
significantly over the study-period.
According to mutation frequency, most of the strains were
weak-mutators (7 out of 12, 58.3%), followed by normo-mutators
(4 out of 12, 33.3%), while only one strain resulted to be a strong-
mutator (8.4%). No hypo-mutators were found (Figure 2C).
Considering the pulsotypes as a whole, pulsotype 1.1 showed
higher frequency compared to pulsotype 2.1 and 2.2 (median: 2.3
× 10−7 vs. 2.7 × 10−8, and 4.6 × 10−8, respectively; p < 0.0001
and 0.05, respectively; Figure 3C). The only hyper-mutator strain
belonged to pulsotype 1.1, while pulsotype 1.2 consisted of weak-
mutators only. The strains belonging to pulsotype 2.1 were
mainly normo-mutators (66.6%), while the remaining ones were
weak-mutators. No significant changes were observed among
strains belonging to each pulsotype.
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FIGURE 3 | Phenotypic traits exhibited by S. maltophilia strains. Results (n = 6, for each strain) are stratified according to the pulsotype: 1.1 (yellow, n = 2
strains), 1.2 (green, n = 3 strains), 2.1 (blue, n = 6 strains), and 2.2 (purple, n = 1 strain). (A) Growth rate. (B) Biofilm biomass formation, normalized on growth rate
(SBF; specific biofilm formation). (C) Mutation frequency; strains were classified into four categories based on mutation frequency (f ): hypo-mutators (f ≤ 8 × 10−9),
normo-mutators (8 × 10−9 < f < 4 × 10−8), weak-mutators (4 × 10−8 ≤ f < 4 × 10−7), and strong-mutators (f ≥ 4 × 10−7). (D) Swimming motility. (E) Twitching
motility. Results are shown as box and whiskers: the box always extends from the 25th to 75th percentiles, while the line in the middle of the box is plotted at the
median. Statistical analysis: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, Kruskal–Wallis followed by Dunn’s multiple comparison post-test.
TABLE 1 | S. maltophilia trends in expression over time across all traits.
Pulsotype (n) Trait
Growth Biofilm Mutation Swimming Twitching G. mellonella A549 cells Antibiotic
rate formation frequency motility motility pathogenicity pathogenicity resistance
1.1 (2)
1.2 (3)
____ ____ ____ ____ ____ ____
2.1 (6)
____ ____
Overall (n = 12)
____ ____ ____ ____ ____ ____
The statistical significance of a trend was assessed by Mann–Whitney-test (pulsotype 1.1) or linear regression analysis (pulsotypes 1.2 and 2.1). Pulsotype 2.2 was not considered
as composed of one strain only. Arrows indicate significant trends: increased (red) or decreased (blue). Trend in antibiotic resistance was measured by considering mean variation in
MIC-values over time, considering only ≥ 4-fold changes.
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The kinetics of the median mutation frequency showed that
in pulsotype 1.1 only strains increased (p < 0.05) their mutation
frequency over the study-period, shifting from weak (ZC2005)-
to strong (ZC2011)-mutator phenotype. No particular trend was
observed for other pulsotypes (Table 1).
Motility
Swimming and twitching motility levels exhibited by
S. maltophilia strains are summarized in Figures 2D,E, 3D,E,
respectively. None of strains showed swarming motility.
Significant differences were found among strains both for
swimming and twitching (p < 0.0001). Particularly, the motility
exhibited by ZC2011 strain was significantly higher compared to
that of ZC2005 (swimming, median: 6.0 vs. 3.5mm, respectively;
p < 0.01; twitching, median: 9 vs. 4mm, respectively; p < 0.001).
With regard to pulsotype 2.1, the motility observed for ZC2006
strain was significantly higher than ZC2008, ZC2013-STM2, and
ZC2014 strains (swimming: 8 vs. 6, 4, and 2mm, respectively;
p < 0.05; twitching: 8.5 vs. 5, 3, and 2mm, respectively;
p < 0.001).
Among strains belonging to pulsotype 1.2, ZC2012-STM1
strain showed a swimming motility significantly lower than
strains ZC2010 and ZC2013-STM1 (7 vs. 10 and 9 mm,
respectively; p < 0.05; Figure 2D). Contrarily, twitching motility
was significantly higher in ZC2010 strain, compared to ZC2012-
STM1 and ZC2013-STM1 strains (14.0 vs. 8.5, and 9 mm,
respectively; p < 0.001; Figure 2E).
With regard to each pulsotype, a similar trend was found
for both swimming and twitching motilities (Figures 3D,E). In
particular, a comparable trend for both swimming and twitching
motilities was observed for the strains belonging to pulsotypes 1.1
and 2.1.
Pulsotype 1.1 showed significantly lower motility, compared
to pulsotypes 1.2 and 2.2 (swimming: 4.5 vs. 9, and 11,
respectively; p< 0.01; twitching: 6 vs. 11 and 11mm, respectively;
p < 0.01), whereas motility exhibited by pulsotype 2.1 (6mm, for
both swimming and twitching) was significantly lower compared
to pulsotypes 1.2 and 2.2 (p < 0.01).
The kinetics of changes in swimming and twitching motilities
over the study-period showed a significant upward trend in
pulsotype 1.1 (p < 0.01), whereas a trend toward decreased
swimming motility was found in pulsotype 2.1 strains (p < 0.05;
Table 1).
Virulence Assays
(i) G. mellonella infection assay. The kinetics of G. mellonella
survival monitored over 96 h following infection with
S. maltophilia showed that the killing activity was generally
dose-dependent, regardless of strain or pulsotype considered
(Figure 4).
To comparatively evaluate the pathogenicity of tested strains,
a “pathogenicity score” was assigned to each strain (Table 2).
ZC2005 was the most virulent strain (score: 8), causing the
killing of all infected larvae already at 24 h and at the lowest
dose used (103 CFU/larva). Other strains showed striking
differences in virulence, except for ZC2010, ZC2012-STM1,
ZC2013-STM1, and ZC2014 strains that resulted to be not
virulent (score: 1), not being able to kill at least 50% of
infected larvae following 96 h-exposure to the highest dose (106
CFU).
Pulsotypes 1.1 and 2.1 showed comparable virulence (mean
score: 5, and median score: 5.5, respectively), significantly higher
than pulsotype 1.2 (median score: 1).
The same trend in virulence was observed, over time, in strains
belonging to pulsotypes 1.1 and 2.1: pathogenicity score in fact
significantly decreased from 8 (ZC2005) to 2 (ZC2011), and from
7 (ZC2006) to 1 (ZC2014), respectively. No change was observed
in pulsotype 1.2 strains (Table 1).
(ii) A549 cells co-culture assay. S. maltophilia pathogenicity
was also assessed on human A549 alveolar cells using
Live/DeadTM cell viability staining (ThermoFisher Scientific;
Figure 5).
Generally, strains significantly differed for pathogenicity level
(p < 0.0001), although a downward trend was observed over
the time (Figure 5A; Table 1). With regard to pulsotype 1.1,
the damage caused by ZC2005 strain was significantly higher
compared to that of ZC2011 (mean percentage ± SD: 46.7 ±
10.0 vs. 17.7 ± 2.1, respectively; p < 0.05). Among pulsotype
1.2 strains, damage significantly decreased from ZC2010 toward
2012-STM1 and ZC2013-STM1 (mean ± SD: 70.4 ± 1.8, 45.8 ±
1.1, and 10.0 ± 1.2, respectively; p < 0.001). Striking significant
differences were also found among strains belonging to pulsotype
2.1, where pathology rate significantly decreased over time from
89.8 ± 3.5 (ZC2006) to 9.1 ± 1.9 (ZC2014) (p < 0.001). Linear
regression analysis confirmed the existence of a negative trend in
each pulsotype (Table 1).
No significant differences were found in cellular damage
among pulsotypes.
However, subtler differences between the temporal profiles
within a pulsotype were observed with regard to non-lethal
effects, including cell rounding and detachment (Figure 5B).
Cells exposed to ZC2010 exhibited unusually high rounding
comparable to ZC2006, whereas ZC2008 consistently showed
high detachment of the epithelial monolayer. The early colonizers
like ZC2005 provoked all three effects, whereas ZC20014 strain
caused minimal damage.
A positive, although statistically not significant, trend was
observed between G. mellonella and A549 assays, considering
results either as a whole (Spearman r: 0.395) or stratified to
pulsotypes 1.1 and 2.1 (Spearman r: 0.550).
Antibiotic Susceptibility
The susceptibility patterns of the sequential S. maltophilia strains
under study were determined by the MIC-test strip method, and
results are shown in Figure 6.
Considering the strains as a whole, MIC of each antibiotic
significantly varied over the study-period: 16 to ≥256µg/ml
(piperacillin-tazobactam), 0.5 to ≥32µg/ml (levofloxacin),
12 to ≥256µg/ml (amikacin), 0.094–0.75 (trimethoprim-
sulfamethoxazole), 0.19–4µg/ml (minocycline), 1 to≥256µg/ml
(ticarcillin-clavulanate), 3–96µg/ml (chloramphenicol), 3 to
≥32µg/ml (ciprofloxacin), and 4 to≥256µg/ml (ceftazidime).
Pulsotype 1.1 strains significantly increased their MIC for
levofloxacin (from 0.75 to 32µg/ml), amikacin (from 4 to
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FIGURE 4 | Survival of Galleria mellonella over 96 h following infection. Each strain was used at the following infective doses prepared in PBS: 106, 105, 104,
and 103 CFU/larva. Uninfected control larvae were exposed to PBS only (black dotted line). Larvae were incubated at 37◦C for 96 h and checked daily for survival,
considering dead those not reactive to touch. Results are shown as mean + SD.
32µg/ml), cotrimoxazole (from 0.94 to 0.5µg/ml), minocycline
(from 0.19 to 4µg/ml), chloramphenicol (from 4 to 48µg/ml),
and ciprofloxacin (from 3 to 32µg/ml), shifting toward resistant
class in the case of chloramphenicol. The mean increase in
MIC-values over time was 18.1-fold.
MIC-values exhibited by the strains belonging to pulsotype
1.2 significantly increased over the study-period, in the case
of levofloxacin (from 1 to 12µg/ml), chloramphenicol (from
4 to 96µg/ml), and ciprofloxacin (from 3 to 32µg/ml). This
resulted in susceptible-to-resistant transition in the case of
levofloxacin and chloramphenicol, but not for ciprofloxacin
whose MICs always indicated resistance. In contrast, MICs
significantly decreased of at least 80-fold for ceftazidime
and ticarcillin/clavulanate (from 250 to 3µg/ml, and from
256 to 1µg/ml, respectively), and of 16-fold for piperacillin-
tazobactam (from 256 to 16µg/ml), switching in all cases from
resistant to susceptible class. Trimethoprim-sulfamethoxazole
MIC increased as well, although the range was within
susceptibility breakpoint (from 0.094 to 0.75µg/ml). The mean
increase in MIC-values over time was 13.6-fold.
Strains belonging to pulsotype 2.1 exhibited increased MICs
for levofloxacin only, passing from susceptible to resistant class
(from 1 to 3µg/ml). The mean increase in MIC-values over time
was 2.8-fold.
Frontiers in Microbiology | www.frontiersin.org 8 September 2016 | Volume 7 | Article 1551
Pompilio et al. S. maltophilia Adaptation to Cystic Fibrosis Lung
TABLE 2 | Pathogenicity of 12 S. maltophilia strains, isolated from the
same CF patient over 10 year-period, as assessed in G. mellonella.
Strains Time (h) required to obtain Pathogenicity
LD50 at the following score
infective doses (CFU/larva)
103 104 105 106
ZC2005 <24 <24 <24 <24 8
ZC2006 24 24 <24 <24 7
ZC2007 72 <24 3
ZC2008 72 24 <24 4
ZC2009 24 24 <24 6
ZC2010 1
ZC2011 24 2
ZC2012-STM1 1
ZC2012-STM2 24 24 <24 6
ZC2013-STM1 1
ZC2013-STM2 48 <24 <24 5
ZC2014 1
Each strain was inoculated, at different doses (103, 104, 105, and 106 CFU/larva), in 20
larvae. Following infection, the larvae mortality was assessed at different times (24, 48, 72,
and 96 h), and LD50 (the dose required to kill 50% of the infected larvae) was recorded. For
each strain, the “pathogenicity score” was calculated assigning decreasing values from
the highest (score: 8) to the lowest (score: 1) virulence, as assessed considering both
dose and time necessary to obtain LD50. In some cases, 24 h-exposure to S. maltophilia
caused the killing of all larvae (LD50 < 24 h). Pulsotypes are indicated by colors: 1.1
(yellow), 1.2 (green), 2.1 (blue), and 2.2 (purple).
The only hyper-mutator strain ZC2011 showed the highest
number of antibiotic resistances. Interestingly, a trend toward
multiple antibiotic resistance among hyper- (4), weak- (2.6 ±
0.97), and normo-mutator (2.3± 0.5) strains was noted, although
this was not statistically significant.
Mutator phenotypes showed higher mean MIC-values
compared to non-mutator phenotype in the case of levofloxacin
(mean ± SD: 1.6 ± 1.1 vs. 6.8 ± 10.9, respectively),
chloramphenicol (mean ± SD: 5.3 ± 2.2 vs. 32.8 ± 41.8,
respectively), and ciprofloxacin (mean ± SD: 5.0 ± 2.0 vs.
14.1 ± 14.8, respectively). However, these differences were not
statistically significant probably due to high SD-values.
In pulsotype 2.1 strains, increased antibiotic resistance was
observed against fluoroquinolones following antibiotic treatment
cycles with levofloxacin or ciprofloxacin.
Trends in S. maltophilia Adaptive
Phenotypes
The phenotypic traits significantly changed in each S. maltophilia
pulsotype over the study-period are summarized in Table 1.
The pattern of evolution followed by S. maltophilia was
dependent on pulsotype considered. Following long-lasting
S. maltophilia infection in CF lung, strains belonging to
pulsotype 1.1 resulted to be the most adapted, being significantly
changed in all traits considered. Pulsotype 2.1 strains showed
variations in all traits but mutation frequency and twitching
motility, sharing with pulsotype 1.1 the same trend for
growth rate, biofilm formation, pathogenicity, and antibiotic
resistance, while an opposite one was observed for swimming
motility. All pulsotypes were affected in A549 pathogenicity
and antibiotic susceptibility. The same temporal trends were
confirmed using non- normalized biofilmOD492-values (data not
shown).
Considering the strains as a whole, we found several
relationships among the phenotypic traits considered (Figure 7).
Swimming and twitching motilities were positively correlated
(Spearman r = 0.876; p < 0.001), whereas a negative
correlation was observed between growth rate and biofilm
formation (Spearman r = −0.720; p < 0.05). Pathogenicity,
as assessed in G. mellonella model, was negatively correlated
both with growth rate (Spearman r = −0.591; p < 0.05)
and levofloxacin MIC (Spearman r = −0.698; p < 0.01),
whereas a positive association was found with biofilm formation
(Spearman r = 0.624; p < 0.05). The mortality observed in
A549 cells was negatively associated with ciprofloxacin MIC
(Spearman r = −0.684; p<0.01). Susceptibility to levofloxacin,
ciprofloxacin and chloramphenicol were positively correlated
each other.
DISCUSSION
In contrast to P. aeruginosa CF lung colonization, where genetic
adaptations leading to phenotypic variation are well known
(Clark et al., 2015), the adaptive characters in S. maltophilia
that drive its persistence in CF lungs is largely unknown. It
is, therefore, interesting to understand trait changes during
S. maltophilia persistence in CF lungs and to evaluate whether
there is a typical phenotypic profile related to chronic infection.
With that aim, the approach followed in this study was to
combine genotypic profiling with phenotypic characterization
to compare sequential S. maltophilia isolates recovered from a
chronically infected CF patient.
The main conclusion arising from our results is the evidence
that during the course of chronic lung colonization S. maltophilia
develops new phenotypes and modulates its pathogenicity,
probably reflecting genetic or epigenetic changes.
S. maltophilia population structure within CF patient airway is
highly dynamic during long-term chronic infection. Our findings
in fact showed that 2 distinct PFGE genotypes, with 4 different
pulsotypes, colonize CF lung over time, and multiple lineages
are present at the same time, as observed during years 2012 and
2013. Further, we observed replacements of infecting genotypes
that, from an ecological perspective, could suggest the existence
of a competition among different genotypes for the same specific
niches of the CF patient lung. The patient harbored pulsotypes
significantly different for isolation frequency over time. A similar
high degree of strain diversity was found by Vidigal et al.
(2014) in S. maltophilia consecutively isolated from chronically
colonized CF patients. A more diverse community reflects niche
separation within the host making bacterial subpopulations
better able to resist an external stress such as exposure to
antibiotics or the human defense system. Our results cannot
provide information if strains come from an environmental
source rather than acquired from another patient, although we
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FIGURE 5 | Effect of S. maltophilia exposure on human A549 alveolar cells. Cell monolayers were exposed for 24 h to each S. maltophilia strain at MOI 500.
The co-culture sets were washed, and then stained with Live/DeadTM assay. Images were acquired by confocal laser scanning microscope, and quantitative image
analysis was performed for fluorescence intensity. (A) The percent cell death was calculated compared to uninfected control samples (CTRL; cell death, 0%). Bar
colors indicate the pulsotypes: 1.1 (yellow, n = 2 strains), 1.2 (green, n = 3 strains), 2.1 (blue, n = 6 strains), and 2.2 (purple, n = 1 strain). Results are expressed as
mean + SD (n = 6). *p < 0.05, unpaired t-test; ◦◦◦p < 0.001, ANOVA followed by Tukey’s multiple comparison post-test. (B) CLSM micrographs of infected A549 cell
monolayers, stained with Syto-9 (green fluorescence, indicating live cells), and propidium iodide (red fluorescence, indicating dead cells). Representative microscopic
fields are shown. Magnification, 100x.
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FIGURE 6 | Antimicrobial susceptibility of S. maltophilia strains. Bar colors indicate the pulsotypes: 1.1 (yellow, n = 2 strains), 1.2 (green, n = 3 strains), 2.1
(blue, n = 6 strains), and 2.2 (purple, n = 1 strain). MIC-values were determined, using the MIC-test strip method, for the following antibiotics: piperacillin/tazobactam
(TZP), levofloxacin (LVX), amikacin (AMK), cotrimoxazole (SXT), minocycline (MIN), ticarcillin/clavulanate (TIM), chloramphenicol (CHL), ciprofloxacin (CIP), and
ceftazidime (CAZ). The dotted line indicates the breakpoint MIC for susceptibility [Clinical Laboratory Standards Institute (CLSI), 2016], when available. Underlined in
red, the years when the antibiotic was therapeutically administered to patient. Information on antibiotic therapy was available for all years but 2005.
recently found that both scenarios are plausible (Pompilio et al.,
2011).
Growth rate is an accepted measure of adaptation and has
been previously used to evaluate fitness deficits associated with
antibiotic resistance (Pope et al., 2008). It has been suggested
that diminished growth rate of P. aeruginosa in the sputum
of chronically infected CF patients is due to the low PMN-
related availability of O2 within the mucus (Kragh et al.,
2014) or, alternatively, to genetic adaptations (Rau et al., 2010).
In contrast, we observed that S. maltophilia growth rate, as
calculated under our experimental setting (TSB medium, 37◦C,
static conditions), increased over time, considering strains both
as a whole and stratified on pulsotype. Our findings suggest that
S. maltophilia, contrarily to P. aeruginosa, might predominantly
colonize respiratory zone (oxygenated due to continuous O2
supply from the venous blood passing alveoli), rather than
the anoxic infectious mucus in the bronchi of the conducting
zone. We also found that growth rate negatively correlated
with biofilm formation. This is consistent with the finding
that slow bacterial growth enhances extracellular polymeric
substance matrix production, therefore allowing stratification of
the bacterial community to form biofilms (Sutherland, 2001).
However, future studies are needed to evaluate if S. maltophilia
fitness could be dependent on medium and conditions used.
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FIGURE 7 | Correlation matrix of phenotype-phenotype associations, as determined by Spearman rank correlation coefficient. (A) p-values: red values in
bold indicate a significant (p < 0.05) correlation between any given phenotype pair. (B) Spearman rank coefficients. Red values in bold indicate a significant (p < 0.05)
correlation between any given phenotype pair: positive and negative values indicate direct and inverse correlations, respectively.
Frontiers in Microbiology | www.frontiersin.org 12 September 2016 | Volume 7 | Article 1551
Pompilio et al. S. maltophilia Adaptation to Cystic Fibrosis Lung
The ability of S. maltophilia cells to form biofilm was reduced
during the late stages of a chronic infection.We recently observed
a reduced efficiency in forming biofilm by S. maltophilia CF
isolates, compared to non-CF ones, probably secondary to the
bacterial adaptation to a stressed environment such as CF lung
(Pompilio et al., 2011). Similarly, P. aeruginosa isolates from
chronically infected patients are often impaired in forming
biofilms (Head and Yu, 2004).
Conditions in CF airways consistently select against bacterial
functions deemed essential for biofilm formation during in
vivo bacterial evolution (Wilder et al., 2009). At early stage
of disease, it is more suitable to increase biofilm formation
to gain benefits including superior access to nutrients and
resistance to environmental insults, such as phagocytosis and
antibiotic treatment. During long-term persistence in the airways
of CF patients, the increased lung damage, a higher prevalence
of co-colonizing pathogens, and increase of neutrophils make
necessary to impair biofilm formation to disseminate in new,
ecologically more favorable, airways locations (Nadell and
Bassler, 2011; Steenackers et al., 2016).
The adaptation of bacterial population to new or challenging
environments normally results in spontaneous generation of
hypermutable strains which display higher mutation frequencies
than their normal counterparts, as a result of defects in the DNA
repair system or proof reading systems. Antibiotics—as well as
host environment—select for these variants, as these undergo
more genetic mutations and are better able to adapt and survive
under the antimicrobial pressures in vivo (Rodriguez-Rojas et al.,
2013).
In CF lung the selection for hypermutable P. aeruginosa
strains becomes more frequent in later stages or chronic
infection in CF patients, suggesting that genetic and phenotypic
diversification plays an essential role in the adaptation of P.
aeruginosa to the hostile and diverse CF lung environment,
probably by selecting for less virulent phenotypes (Hogardt et al.,
2007; Oliver, 2010).
Interestingly we did not observe hypermutability in our
panel of S. maltophilia strains. Half of S. maltophilia strains
we tested were in fact weak mutators, while only one strain
(8.4%) was hypermutator. These observations are similar to that
reported by O’Neill and Chopra (2002) in S. aureus clinical
isolates, but contrary to findings by Vidigal et al. (2014) who
observed comparable frequency of strong- (31.2%) and weak-
mutators (27.7%), and a lower frequency of hypomutators
(17.7%), in 90 S. maltophilia isolates collected from the sputum
of 19 CF patients considered chronically colonized. However,
in agreement with this study, we found that mutation rates
of the most clonally related genotypes varied over time with
the tendency to become less mutable, except for pulsotype
1.1 that significantly increased mutation frequency over time.
We are tempted to hypothesize that mutation frequency does
not contribute significantly to the adaptation of S. maltophilia
population to CF lung. However, this discrepancy could be also
due to the small number of strains we tested, therefore warranting
further studies on larger populations.
The bacterial colonization of CF airways is mediated by the
adhesion of cell appendages such as flagellum and type IV pili
to host epithelial cell surface. Our findings revealed that in
S. maltophilia motility changes during long-term colonization
depend on the pulsotype considered. Swimming motility is well
described as an adaptive trait in P. aeruginosa infections in
CF whereby in contrast to initially infecting motile strains,
chronic ones are characterized by the lack of swimming
motility due to the loss of the flagellum (Huse et al., 2013).
We observed a similar trend for pulsotype 2.1 strains whose
swimming motility significantly decreased over study-period.
The potential reason for this phenotypic selection in vivo is
that the decreased flagellar motility may enable S. maltophilia
to better evade immune recognition and airway clearance by
phagocytosis. Several studies have in fact shown the inability
of macrophages to phagocytose non-flagellated P. aeruginosa
isolates (Mahenthiralingam et al., 1994), and the reduced
inflammasome activation and antibacterial IL-1β host response
following the loss in motility (Patankar et al., 2013).
Inversely, strains belonging to pulsotype 1.1 significantly
increased swimming and twitching motilities during
chronicization. In agreement with our findings, Burkholderia
cenocepacia complex isolates from chronic infections were
found not to lose swimming motility (Zlosnik et al., 2014), even
showing increased expression in genes associated with flagella
assembly and adhesion during the late stage of infection (Mira
et al., 2011). We do not know the significance of this observation,
although this trend could be due to the small number of strains
(n= 2) belonging to pulsotype 1.1.
In partial agreement with our previous findings (Pompilio
et al., 2011), swimming and twitching motility were positively
correlated, but neither associated with biofilm formation.
Although it is generally agreed that motility and biofilm
development are mutually exclusive events (Belas, 2013), flagella
are not only required as a mechanical device for propulsion, but
also play a critical role in the initial stages of surface adhesion
that leads to the formation of a biofilm, therefore representing
attractive therapeutic targets (Erhardt, 2016).
Accumulating evidences support that S. maltophilia exhibits
plethora of pathogenic determinants to exert its association with
human respiratory epithelium. These determinants are unique
in context of this pathogen’s limited virulence that limits its
invasive potential in comparison to other evolved pathogens like
P. aeruginosa. However, S. maltophilia is increasingly known to
employ multifactorial determinants like extracellular proteases
(Karaba et al., 2013), host cell actin modifiers (MacDonald
et al., 2016), quorum signaling molecules (Huedo et al., 2015),
and highly evolved eﬄux-pumps (Chang et al., 2015), which
independently or together offer formidable recalcitrance and
pathogenic fitness.
P. aeruginosa adaptation in CF airways selects patho-adaptive
variants with a strongly reduced ability to cause acute infection
processes in a host-independent way (Hoboth et al., 2009;
Folkesson et al., 2012; Lorè et al., 2012). Consistent with these
findings, our data clearly showed that the virulence potential
of S. maltophilia plays little if any role in its ability to persist
in CF airways. Pathogenicity, as measured with similar trends
both in G. mellonella and human lung epithelial cells, was
in fact severely reduced over time. This result indicates a
host-pathogen relationship that results in attenuated virulence
and pathogenicity during the establishment of chronic infection.
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Virulence factors or determinants are in fact often non-essential
to the pathogen and, consequently, are lost (Brown et al., 2012).
Further studies are needed to evaluate whether reduced virulence
in S. maltophilia is itself adaptive in terms of helping bacterial
cells to go unnoticed by host immune system (Gama et al., 2012)
or resist antibiotic therapy (Malone et al., 2010), or if it is a
pleiotropic cost associated with other within-host adaptation.
However, despite decreased virulence S. maltophilia might
retain the ability to contribute to disease pathogenesis in CF
lung by inducing high proinflammatory cytokine and adhesion
molecule expression, as described in P. aeruginosa (Hawdon
et al., 2010). In this regard, we observed that S. maltophilia
biofilm formation efficiency, although decreased over time, is
directly associated with mortality rate in G. mellonella, a finding
supported elsewhere for Candida albicans and Cryptococcus
neoformans (Cirasola et al., 2013; Benaducci et al., 2016).
Chronic respiratory infections by S. maltophilia are very
difficult to treat due to bacterial intrinsic resistance to a wide
number of antibiotics, and ability to develop high-level resistance
during antibiotic treatment and to adapt to and resist other
adverse environmental conditions (Ryan et al., 2009; Chang et al.,
2015). Although we observed variable resistance profiles along
the study period, as a general trend evolution toward lower
levels of susceptibility to antibiotics was observed over time,
in terms of mean increase in MIC-values and accumulation
of resistances. Interestingly, in the case of levofloxacin and
chloramphenicol, MIC changes even resulted in susceptible-
to-resistant category transition. All strains were susceptible to
cotrimoxazole and mynocycline, although a genotype-dependent
trend toward higher MIC-values was observed over time for both
antibiotics. Our findings could have significant implications in
the management of CF patients since these drugs are considered
first-line therapeutic choices for S. maltophilia infections (Wei
et al., 2016).
Fluoroquinolones are commonly used to treat infections
due to S. maltophilia. However, their overuse worldwide
has resulted in higher resistance rates in many kinds of
pathogenic bacteria, including S. maltophilia (Pien et al.,
2015). In this respect, following administration of parental or
inhaled fluoroquinolones therapy reduced susceptibility to both
ciprofloxacin and levofloxacin was observed in pulsotype 2.1
strains. The ability of S. maltophilia to develop resistance during
antibiotic treatment is in agreement with the generalized idea
that this adaptive mechanism is among the important features
contributing to persistent infection.
No correlation could be established between antibiotic
resistance and the amount of the biofilm formed, indicating that
other relevant mechanismsmight also contribute to the increased
resistance registered toward several antimicrobials of different
classes. In this regard, contrarily to Vidigal et al. (2014), we
found higher MIC-values in mutator strains compared to non-
mutator ones. A correlation between S. maltophilia mutators
and increasing antibiotic resistance was found namely for
ciprofloxacin, levofloxacin, and chloramphenicol. It is thought
that the genetic and phenotypic changes that confer resistance
also result in concomitant reductions in in vivo virulence
(Cameron et al., 2015). For the first time, the present work
described in S. maltophilia a direct relationship between the
development of resistance to fluoroquinolones and reduced
pathogenicity.
Taken together, our results show that S. maltophilia is a
versatile pathogen which can adapt successfully to a highly
stressful environment such as CF lung. To this, S. maltophilia
pays a “biological cost,” as suggested by the presence of relevant
genotypic and phenotypic heterogeneity within a bacterial
population chronically infecting the CF lung. A number of
social traits are in fact changed over time, probably as a result
of evolution within a lineage, or by displacement of one by
another lineage. Although adaptation occurred with selection of
substantially different S. maltophilia phenotypes, depending on
genotype considered, it was possible to detect a general trend
of adaptation toward less virulence and increased antibiotic
resistance in our investigated isolates.
S. maltophilia adaptation, measured as number of changed
traits, is associated with length of persistence. In addition, the
establishment of a highly heterogeneous bacterial population,
suggestive for niche separation in the host by different strains,
indicates that populations are significantly more complex and
dynamic than can be described by the analysis of any single
isolate and can fluctuate rapidly to changing selective pressures.
Although the differences at the genetic or epigenetic level
giving rise to phenotypic variability in CF isolates are not yet
known, our results gained new insights into the behavior of
S. maltophilia during persistence in CF lung that will hopefully
help to identify vulnerabilities and potential targets for the
development of treatment strategies directed at chronic infection.
The main limitation of the present study is that having
considered only one chronically infected patient does not
allow us to evaluate if the adaptation process may relate
to the complexity of the individual host niche. In future
investigations, we plan to expand the number of patients in
order to: (i) study the precise microenvironmental pressures
driving diversification we observed among phenotypic traits
within S. maltophilia populations in the CF lung; (ii) identify
specific genetic determinants contributing to such diversity,
by using of whole genome sequencing of large numbers of
isolates coupled with phenotypic characterization and genome-
wide association analyses; and (iii) evaluate other phenotypic
adaptations classically involved during progression from acute
to chronic infection (i.e., exopolysaccharide production, quorum
sensing, expression of virulence factors associated with chronic
infection).
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